| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 7.67e-11 | 21 | 140 | 7 | GO:0034987 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 7.97e-08 | 7 | 140 | 4 | GO:0034988 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 3.34e-06 | 5 | 140 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | antigen binding | 3.92e-04 | 190 | 140 | 7 | GO:0003823 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 3.41e-09 | 10 | 141 | 5 | GO:0016068 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 1.46e-08 | 25 | 141 | 6 | GO:0002524 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.71e-08 | 13 | 141 | 5 | GO:0001788 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 1.86e-08 | 44 | 141 | 7 | GO:0006958 | |
| GeneOntologyBiologicalProcess | complement activation | 2.58e-08 | 70 | 141 | 8 | GO:0006956 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 3.95e-08 | 15 | 141 | 5 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 3.95e-08 | 15 | 141 | 5 | GO:0002445 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 1.21e-07 | 85 | 141 | 8 | GO:0019731 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.43e-07 | 8 | 141 | 4 | GO:0001812 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 1.50e-07 | 19 | 141 | 5 | GO:0002883 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 2.16e-07 | 62 | 141 | 7 | GO:0002455 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 2.57e-07 | 9 | 141 | 4 | GO:0001810 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 3.93e-07 | 42 | 141 | 6 | GO:0002438 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 4.26e-07 | 10 | 141 | 4 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 4.26e-07 | 10 | 141 | 4 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 6.65e-07 | 11 | 141 | 4 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 6.65e-07 | 11 | 141 | 4 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 9.94e-07 | 27 | 141 | 5 | GO:0002864 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 1.15e-06 | 79 | 141 | 7 | GO:0050853 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 2.69e-06 | 15 | 141 | 4 | GO:0002885 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 4.65e-06 | 17 | 141 | 4 | GO:0002866 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.71e-06 | 187 | 141 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM PCDHA13 PCDHA8 PCDHA6 DSCAML1 PTK7 LRFN4 CELSR3 CLDN20 ROBO3 SDK1 | 1.05e-05 | 313 | 141 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 1.67e-05 | 23 | 141 | 4 | GO:0002863 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 2.30e-05 | 50 | 141 | 5 | GO:0045022 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 3.89e-05 | 238 | 141 | 9 | GO:0050954 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 4.01e-05 | 56 | 141 | 5 | GO:0098927 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 4.29e-05 | 186 | 141 | 8 | GO:0019730 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | IRGM DSCAM SPN NEXMIF PCDHA13 AMBRA1 PCDHA8 PCDHA6 FNDC3A ZMIZ1 AQP4 DSCAML1 PTK7 NEO1 LRFN4 CELSR3 CLDN20 ROBO3 TNXB SDK1 | 4.47e-05 | 1077 | 141 | 20 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 4.99e-05 | 30 | 141 | 4 | GO:0002888 | |
| GeneOntologyBiologicalProcess | neuron development | PLXNA3 DSCAM ABI3BP TRIO KIF26A PLK5 ZMIZ1 TECTA DSCAML1 PTK7 SPTBN4 NEO1 KANK1 IGF1R CELSR3 ITSN2 PTPRQ MAP3K13 ROBO3 TNXB SDK1 STRCP1 OTOG EPHA8 | 5.30e-05 | 1463 | 141 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 DSCAM ABI3BP TRIO TECTA DSCAML1 PTK7 SPTBN4 NEO1 IGF1R CELSR3 PTPRQ MAP3K13 ROBO3 STRCP1 EPHA8 | 5.40e-05 | 748 | 141 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection development | PLXNA3 DSCAM ABI3BP TRIO KIF26A PLK5 TECTA DSCAML1 PTK7 SPTBN4 NEO1 KANK1 IGF1R CELSR3 ITSN2 MAP3K13 ROBO3 TNXB SDK1 STRCP1 OTOG EPHA8 | 6.06e-05 | 1285 | 141 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 6.08e-05 | 61 | 141 | 5 | GO:0002861 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | PLXNA3 DSCAM LIMD1 ABI3BP TRIO TECTA DSCAML1 PTK7 SPTBN4 NEO1 KANK1 IGF1R CELSR3 ITSN2 PTPRQ PRKDC MAP3K13 CFAP70 ROBO3 STRCP1 EPHA8 | 6.20e-05 | 1194 | 141 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 6.67e-05 | 198 | 141 | 8 | GO:0007605 | |
| GeneOntologyBiologicalProcess | cell recognition | 6.67e-05 | 198 | 141 | 8 | GO:0008037 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 7.41e-05 | 201 | 141 | 8 | GO:0030183 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 7.61e-05 | 103 | 141 | 6 | GO:0002437 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 9.55e-05 | 67 | 141 | 5 | GO:0002673 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | IRGM SPN MUC19 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 DMBT1 | 1.10e-04 | 405 | 141 | 11 | GO:0042742 |
| GeneOntologyBiologicalProcess | axon guidance | 1.54e-04 | 285 | 141 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.58e-04 | 286 | 141 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 1.91e-04 | 42 | 141 | 4 | GO:0002675 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 1.91e-04 | 42 | 141 | 4 | GO:0006910 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 2.35e-04 | 81 | 141 | 5 | GO:0002886 | |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 2.37e-04 | 18 | 141 | 3 | GO:0070593 | |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 2.78e-04 | 84 | 141 | 5 | GO:0008333 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 3.06e-04 | 187 | 141 | 7 | GO:0007034 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | IRGM SPN MUC19 AMBRA1 ZMIZ1 IGHE IGHG1 IGHG2 IGHG3 IGHG4 PRKDC SLC39A7 | 3.26e-04 | 537 | 141 | 12 | GO:0030098 |
| GeneOntologyBiologicalProcess | humoral immune response | 3.72e-04 | 321 | 141 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | acute inflammatory response | 4.55e-04 | 143 | 141 | 6 | GO:0002526 | |
| GeneOntologyBiologicalProcess | defense response to symbiont | IRGM SPN TRIM26 MUC19 UNC13D ATG14 PARP14 AQP4 IFIT2 CFB IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 PRKDC DMBT1 NLRC3 | 4.76e-04 | 1286 | 141 | 20 | GO:0140546 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | PLXNA3 DSCAM ABI3BP TRIO DSCAML1 PTK7 SPTBN4 NEO1 KANK1 IGF1R CELSR3 ITSN2 MAP3K13 ROBO3 EPHA8 | 4.95e-04 | 819 | 141 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 5.16e-04 | 96 | 141 | 5 | GO:0060113 | |
| GeneOntologyBiologicalProcess | axonogenesis | PLXNA3 DSCAM TRIO DSCAML1 PTK7 SPTBN4 NEO1 IGF1R CELSR3 MAP3K13 ROBO3 EPHA8 | 5.21e-04 | 566 | 141 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | PLXNA3 DSCAM ABI3BP TRIO DSCAML1 PTK7 SPTBN4 NEO1 KANK1 IGF1R CELSR3 ITSN2 MAP3K13 ROBO3 EPHA8 | 5.41e-04 | 826 | 141 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 5.46e-04 | 148 | 141 | 6 | GO:0002444 | |
| GeneOntologyBiologicalProcess | B cell activation | 5.75e-04 | 341 | 141 | 9 | GO:0042113 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 5.83e-04 | 56 | 141 | 4 | GO:0002714 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 5.83e-04 | 56 | 141 | 4 | GO:0002891 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 6.07e-04 | 151 | 141 | 6 | GO:0007041 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | IRGM ERBB4 CEP85 HTR2B DSCAM SPN ARHGEF5 AMBRA1 ATG14 PARP14 SPTBN4 IGF1R CELSR3 PTPRH PTPRQ SPRED1 PRKDC MAP3K13 TNXB PRXL2C WNK3 | 6.63e-04 | 1421 | 141 | 21 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | IRGM ERBB4 CEP85 HTR2B DSCAM SPN ARHGEF5 AMBRA1 ATG14 PARP14 SPTBN4 IGF1R CELSR3 PTPRH PTPRQ SPRED1 PRKDC MAP3K13 TNXB PRXL2C WNK3 | 6.75e-04 | 1423 | 141 | 21 | GO:0051174 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | IRGM ERBB4 CEP85 HTR2B DSCAM SPN ARHGEF5 ATG14 PARP14 SPTBN4 IGF1R CELSR3 PTPRH PTPRQ SPRED1 PRKDC MAP3K13 TNXB WNK3 | 6.95e-04 | 1226 | 141 | 19 | GO:0042325 |
| GeneOntologyBiologicalProcess | neuron recognition | 7.12e-04 | 59 | 141 | 4 | GO:0008038 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 7.43e-04 | 104 | 141 | 5 | GO:0042490 | |
| GeneOntologyBiologicalProcess | neuron migration | 7.64e-04 | 218 | 141 | 7 | GO:0001764 | |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 8.73e-04 | 223 | 141 | 7 | GO:0050851 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 9.53e-04 | 7 | 141 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 9.53e-04 | 7 | 141 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 1.18e-03 | 235 | 141 | 7 | GO:0016064 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | PLXNA3 DSCAM ABI3BP TRIO DSCAML1 PTK7 SPTBN4 NEO1 IGF1R CELSR3 ITSN2 MAP3K13 ROBO3 EPHA8 | 1.21e-03 | 802 | 141 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 1.27e-03 | 238 | 141 | 7 | GO:0048639 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 1.28e-03 | 69 | 141 | 4 | GO:0006911 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.35e-03 | 385 | 141 | 9 | GO:0051251 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.11e-11 | 17 | 143 | 7 | GO:0042571 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 2.66e-08 | 14 | 143 | 5 | GO:0071735 | |
| GeneOntologyCellularComponent | manchette | 3.78e-05 | 28 | 143 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | blood microparticle | 6.09e-05 | 144 | 143 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | dimeric IgA immunoglobulin complex | 1.39e-04 | 3 | 143 | 2 | GO:0071750 | |
| GeneOntologyCellularComponent | secretory dimeric IgA immunoglobulin complex | 1.39e-04 | 3 | 143 | 2 | GO:0071752 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.48e-04 | 166 | 143 | 7 | GO:0019814 | |
| MousePheno | enhanced humoral immune response | 3.12e-09 | 17 | 115 | 6 | MP:0020155 | |
| MousePheno | absent memory B cells | 4.35e-09 | 4 | 115 | 4 | MP:0008094 | |
| MousePheno | decreased memory B cell number | 5.31e-07 | 9 | 115 | 4 | MP:0008729 | |
| MousePheno | increased plasma cell number | 8.31e-07 | 40 | 115 | 6 | MP:0008097 | |
| MousePheno | decreased IgG2c level | 1.37e-06 | 11 | 115 | 4 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 1.37e-06 | 11 | 115 | 4 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 4.08e-06 | 14 | 115 | 4 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 5.53e-06 | 15 | 115 | 4 | MP:0008099 | |
| MousePheno | abnormal plasma cell number | 8.59e-06 | 59 | 115 | 6 | MP:0008096 | |
| MousePheno | abnormal IgG2c level | 2.33e-05 | 21 | 115 | 4 | MP:0020178 | |
| MousePheno | abnormal plasma cell morphology | 3.45e-05 | 75 | 115 | 6 | MP:0002439 | |
| MousePheno | increased germinal center B cell number | 1.15e-04 | 31 | 115 | 4 | MP:0008177 | |
| MousePheno | thick retina inner plexiform layer | 2.00e-04 | 3 | 115 | 2 | MP:0014265 | |
| Domain | FN3 | DSCAM ABI3BP MYOM3 FNDC3A DSCAML1 RIMBP3 NEO1 LRFN4 IGF1R PTPRH RIMBP3C ROBO3 RIMBP3B USH2A TNXB SDK1 EPHA8 | 1.46e-13 | 199 | 140 | 17 | PS50853 |
| Domain | FN3_dom | DSCAM ABI3BP MYOM3 FNDC3A DSCAML1 RIMBP3 NEO1 LRFN4 IGF1R PTPRH RIMBP3C ROBO3 RIMBP3B USH2A TNXB SDK1 EPHA8 | 3.27e-13 | 209 | 140 | 17 | IPR003961 |
| Domain | Ig-like_fold | PLXNA3 FCRL2 DSCAM ABI3BP TRIO MYOM3 FNDC3A DSCAML1 PTK7 RIMBP3 NEO1 LRFN4 IGF1R PTPRH IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 RIMBP3C ROBO3 RIMBP3B USH2A TNXB SDK1 EPHA8 | 3.58e-13 | 706 | 140 | 28 | IPR013783 |
| Domain | FN3 | DSCAM ABI3BP MYOM3 FNDC3A DSCAML1 NEO1 LRFN4 IGF1R PTPRH RIMBP3C ROBO3 RIMBP3B USH2A TNXB SDK1 EPHA8 | 6.54e-13 | 185 | 140 | 16 | SM00060 |
| Domain | fn3 | DSCAM ABI3BP MYOM3 FNDC3A DSCAML1 NEO1 LRFN4 IGF1R PTPRH ROBO3 USH2A TNXB SDK1 EPHA8 | 1.96e-11 | 162 | 140 | 14 | PF00041 |
| Domain | - | PLXNA3 FCRL2 DSCAM ABI3BP TRIO MYOM3 FNDC3A DSCAML1 PTK7 RIMBP3 NEO1 LRFN4 IGF1R RIMBP3C ROBO3 RIMBP3B USH2A TNXB SDK1 EPHA8 | 1.16e-07 | 663 | 140 | 20 | 2.60.40.10 |
| Domain | C1-set | 1.51e-07 | 54 | 140 | 7 | PF07654 | |
| Domain | IG_LIKE | FCRL2 DSCAM TRIO MYOM3 DSCAML1 PTK7 NEO1 LRFN4 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 ROBO3 SDK1 | 1.65e-07 | 491 | 140 | 17 | PS50835 |
| Domain | IGc1 | 1.95e-07 | 56 | 140 | 7 | SM00407 | |
| Domain | Ig-like_dom | FCRL2 DSCAM TRIO MYOM3 DSCAML1 PTK7 NEO1 LRFN4 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 ROBO3 SDK1 | 2.32e-07 | 503 | 140 | 17 | IPR007110 |
| Domain | Ig/MHC_CS | 2.50e-07 | 58 | 140 | 7 | IPR003006 | |
| Domain | Ig_C1-set | 2.50e-07 | 58 | 140 | 7 | IPR003597 | |
| Domain | IG_MHC | 3.17e-07 | 60 | 140 | 7 | PS00290 | |
| Domain | Ig_I-set | 1.71e-06 | 190 | 140 | 10 | IPR013098 | |
| Domain | I-set | 1.71e-06 | 190 | 140 | 10 | PF07679 | |
| Domain | SH3_9 | 1.94e-06 | 78 | 140 | 7 | PF14604 | |
| Domain | SH3_2 | 3.75e-06 | 86 | 140 | 7 | PF07653 | |
| Domain | SH3_2 | 3.75e-06 | 86 | 140 | 7 | IPR011511 | |
| Domain | IGc2 | 1.13e-05 | 235 | 140 | 10 | SM00408 | |
| Domain | Ig_sub2 | 1.13e-05 | 235 | 140 | 10 | IPR003598 | |
| Domain | SH3 | ARHGAP42 SH3TC2 TRIO ARHGEF5 RIMBP3 ITSN2 MAP3K9 RIMBP3C RIMBP3B | 3.71e-05 | 216 | 140 | 9 | SM00326 |
| Domain | SH3 | ARHGAP42 SH3TC2 TRIO ARHGEF5 RIMBP3 ITSN2 MAP3K9 RIMBP3C RIMBP3B | 3.71e-05 | 216 | 140 | 9 | PS50002 |
| Domain | SH3_domain | ARHGAP42 SH3TC2 TRIO ARHGEF5 RIMBP3 ITSN2 MAP3K9 RIMBP3C RIMBP3B | 4.28e-05 | 220 | 140 | 9 | IPR001452 |
| Domain | ARHGEF5_35 | 5.58e-05 | 2 | 140 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 5.58e-05 | 2 | 140 | 2 | IPR029212 | |
| Domain | C8 | 8.63e-05 | 12 | 140 | 3 | PF08742 | |
| Domain | TIL | 8.63e-05 | 12 | 140 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 1.12e-04 | 13 | 140 | 3 | IPR014853 | |
| Domain | C8 | 1.12e-04 | 13 | 140 | 3 | SM00832 | |
| Domain | TIL_dom | 1.41e-04 | 14 | 140 | 3 | IPR002919 | |
| Domain | VWF_type-D | 2.15e-04 | 16 | 140 | 3 | IPR001846 | |
| Domain | VWFD | 2.15e-04 | 16 | 140 | 3 | PS51233 | |
| Domain | VWD | 2.15e-04 | 16 | 140 | 3 | SM00216 | |
| Domain | VWD | 2.15e-04 | 16 | 140 | 3 | PF00094 | |
| Domain | VWC_out | 3.66e-04 | 19 | 140 | 3 | SM00215 | |
| Domain | Tyr_kinase_cat_dom | 5.24e-04 | 88 | 140 | 5 | IPR020635 | |
| Domain | TyrKc | 5.24e-04 | 88 | 140 | 5 | SM00219 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.09e-04 | 138 | 140 | 6 | IPR001245 | |
| Domain | Recep_L_domain | 1.14e-03 | 7 | 140 | 2 | PF01030 | |
| Domain | Furin-like | 1.14e-03 | 7 | 140 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.14e-03 | 7 | 140 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 1.14e-03 | 7 | 140 | 2 | IPR006211 | |
| Domain | - | 1.14e-03 | 7 | 140 | 2 | 3.80.20.20 | |
| Domain | IG | 1.29e-03 | 421 | 140 | 10 | SM00409 | |
| Domain | Ig_sub | 1.29e-03 | 421 | 140 | 10 | IPR003599 | |
| Domain | Ptc/Disp | 1.94e-03 | 9 | 140 | 2 | IPR003392 | |
| Domain | Patched | 1.94e-03 | 9 | 140 | 2 | PF02460 | |
| Domain | Na_channel_asu | 2.41e-03 | 10 | 140 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.41e-03 | 10 | 140 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.41e-03 | 10 | 140 | 2 | PF06512 | |
| Domain | ZP_dom_CS | 2.41e-03 | 10 | 140 | 2 | IPR017977 | |
| Domain | Cadherin_tail | 2.66e-03 | 37 | 140 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 2.66e-03 | 37 | 140 | 3 | IPR031904 | |
| Domain | Pkinase_Tyr | 2.88e-03 | 129 | 140 | 5 | PF07714 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.89e-05 | 54 | 94 | 5 | MM14655 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.23e-04 | 15 | 94 | 3 | MM14965 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.28e-04 | 39 | 94 | 4 | MM17212 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 2.05e-04 | 44 | 94 | 4 | M875 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.41e-04 | 84 | 94 | 5 | MM14653 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 2.88e-04 | 48 | 94 | 4 | MM17214 | |
| Pubmed | 1.13e-13 | 15 | 144 | 7 | 20176268 | ||
| Pubmed | 1.13e-12 | 5 | 144 | 5 | 6421489 | ||
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 6.29e-11 | 8 | 144 | 5 | 30205047 | |
| Pubmed | 6.29e-11 | 8 | 144 | 5 | 32601467 | ||
| Pubmed | 2.81e-10 | 10 | 144 | 5 | 31042473 | ||
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 2.82e-10 | 4 | 144 | 4 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 2.82e-10 | 4 | 144 | 4 | 11812141 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6794027 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 2.82e-10 | 4 | 144 | 4 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 2.82e-10 | 4 | 144 | 4 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 2.82e-10 | 4 | 144 | 4 | 19050247 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6407005 | ||
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 2.82e-10 | 4 | 144 | 4 | 30287618 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 7892607 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 4565406 | ||
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 2.82e-10 | 4 | 144 | 4 | 25363774 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 20621099 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 2.82e-10 | 4 | 144 | 4 | 12414967 | |
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 2.82e-10 | 4 | 144 | 4 | 8438159 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 4098598 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 2.82e-10 | 4 | 144 | 4 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 2.82e-10 | 4 | 144 | 4 | 6803173 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6264445 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 2.82e-10 | 4 | 144 | 4 | 25867470 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 1542303 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 2.82e-10 | 4 | 144 | 4 | 9126488 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 8452816 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 4831970 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 7439686 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6278424 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 35133976 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 8099342 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 2.82e-10 | 4 | 144 | 4 | 32006024 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 12209645 | ||
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 2.82e-10 | 4 | 144 | 4 | 117549 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 116231 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 25451975 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 2.82e-10 | 4 | 144 | 4 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 2.82e-10 | 4 | 144 | 4 | 6801765 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6306571 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 1672339 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 2.82e-10 | 4 | 144 | 4 | 1713710 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 2.82e-10 | 4 | 144 | 4 | 9103199 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 2.82e-10 | 4 | 144 | 4 | 98524 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 38268239 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 2.82e-10 | 4 | 144 | 4 | 6799207 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6787604 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6170065 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 2.82e-10 | 4 | 144 | 4 | 19703988 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 2.82e-10 | 4 | 144 | 4 | 6767246 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 12051834 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 8683112 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 2.82e-10 | 4 | 144 | 4 | 807855 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 4166666 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 26201558 | ||
| Pubmed | Nucleotide sequence of a human immunoglobulin C gamma 4 gene. | 2.82e-10 | 4 | 144 | 4 | 6299662 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6249338 | ||
| Pubmed | Linkage and sequence homology of two human immunoglobulin gamma heavy chain constant region genes. | 2.82e-10 | 4 | 144 | 4 | 6804948 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 2.82e-10 | 4 | 144 | 4 | 19592272 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 10720538 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 24752300 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 15699144 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 2513486 | ||
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 36763580 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 2.82e-10 | 4 | 144 | 4 | 3921826 | |
| Pubmed | 2.82e-10 | 4 | 144 | 4 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 2.82e-10 | 4 | 144 | 4 | 26683050 | |
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 2.82e-10 | 4 | 144 | 4 | 6766534 | |
| Pubmed | IgH isotype-specific B cell receptor expression influences B cell fate. | 8.78e-10 | 12 | 144 | 5 | 28923960 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 1.40e-09 | 5 | 144 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 1.40e-09 | 5 | 144 | 4 | 6770027 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 1.40e-09 | 5 | 144 | 4 | 7704573 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 1.40e-09 | 5 | 144 | 4 | 20031218 | |
| Pubmed | Human and murine immunoglobulin expression vector cassettes. | 1.40e-09 | 5 | 144 | 4 | 11257305 | |
| Pubmed | A novel allele for inducible Cre expression in germinal center BÂ cells. | 1.40e-09 | 5 | 144 | 4 | 30359469 | |
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 9834201 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 103631 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 33163250 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 6327276 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 37310381 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 36853944 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 23423996 | ||
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 1.40e-09 | 5 | 144 | 4 | 5073237 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 1.40e-09 | 5 | 144 | 4 | 35044826 | |
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 1.40e-09 | 5 | 144 | 4 | 22249450 | |
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 1.40e-09 | 5 | 144 | 4 | 26620759 | |
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 32640012 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 32229726 | ||
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 1.40e-09 | 5 | 144 | 4 | 34539636 | |
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 3031474 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 33025844 | ||
| Pubmed | 1.40e-09 | 5 | 144 | 4 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 1.40e-09 | 5 | 144 | 4 | 6798155 | |
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 1.40e-09 | 5 | 144 | 4 | 24548411 | |
| Interaction | GOLGA8A interactions | 3.99e-06 | 35 | 139 | 5 | int:GOLGA8A | |
| Interaction | IGHV4-31 interactions | 1.75e-05 | 8 | 139 | 3 | int:IGHV4-31 | |
| Interaction | DUSP18 interactions | 2.07e-05 | 24 | 139 | 4 | int:DUSP18 | |
| Interaction | GNG8 interactions | 2.58e-05 | 125 | 139 | 7 | int:GNG8 | |
| Interaction | PHF11 interactions | 4.66e-05 | 137 | 139 | 7 | int:PHF11 | |
| Interaction | UBE2U interactions | 5.11e-05 | 139 | 139 | 7 | int:UBE2U | |
| Interaction | EBF2 interactions | 5.39e-05 | 59 | 139 | 5 | int:EBF2 | |
| Interaction | ITLN2 interactions | 5.39e-05 | 59 | 139 | 5 | int:ITLN2 | |
| Cytoband | 14q32.33 | 4.99e-08 | 228 | 144 | 9 | 14q32.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 1.32e-05 | 566 | 144 | 10 | chr14q32 | |
| Cytoband | 22q11.21 | 4.29e-04 | 111 | 144 | 4 | 22q11.21 | |
| GeneFamily | Fibronectin type III domain containing | DSCAM ABI3BP MYOM3 FNDC3A DSCAML1 NEO1 LRFN4 IGF1R PTPRH PTPRQ ROBO3 USH2A TNXB SDK1 EPHA8 | 2.66e-14 | 160 | 106 | 15 | 555 |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.42e-07 | 161 | 106 | 9 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 1.80e-05 | 193 | 106 | 8 | 594 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 1.16e-04 | 187 | 106 | 7 | 349 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.08e-04 | 66 | 106 | 4 | 722 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.19e-03 | 9 | 106 | 2 | 1203 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 8.55e-08 | 21 | 143 | 5 | M39281 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 6.04e-06 | 235 | 143 | 9 | MM978 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 6.94e-06 | 23 | 143 | 4 | M1115 | |
| Coexpression | UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN | 8.73e-06 | 8 | 143 | 3 | M48298 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 9.83e-06 | 25 | 143 | 4 | MM480 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 2.83e-05 | 219 | 143 | 8 | M41199 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE | 3.13e-05 | 162 | 143 | 7 | M41204 | |
| Coexpression | WATANABE_COLON_CANCER_MSI_VS_MSS_DN | 3.82e-05 | 69 | 143 | 5 | M8976 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP | 4.37e-05 | 13 | 143 | 3 | M40999 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 6.11e-05 | 180 | 143 | 7 | M8239 | |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN | 8.45e-05 | 16 | 143 | 3 | M41742 | |
| Coexpression | HAY_BONE_MARROW_PLASMA_CELL | 8.84e-05 | 132 | 143 | 6 | M39205 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 8.89e-05 | 43 | 143 | 4 | MM799 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 1.69e-05 | 24 | 139 | 4 | Arv_SC-H9hpx_500_K4 | |
| ToppCell | IIH-naiveBc|IIH / Condition, Cell_class and T cell subcluster | FCRL2 TRIO SLC6A16 RIMBP3 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 8.61e-12 | 168 | 144 | 11 | 8450ed6720d308c711dfbc76652e5821be7b8e93 |
| ToppCell | IIH-naiveBc-|IIH / Condition, Cell_class and T cell subcluster | FCRL2 TRIO SLC6A16 RIMBP3 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 8.61e-12 | 168 | 144 | 11 | 27b500f79aedc4669988670c92ff1a47dcbdf2a0 |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | FCRL2 TICRR FNDC3A GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 | 2.60e-11 | 186 | 144 | 11 | 66676d9395172de5707e204826a1c9f73b448cca |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | FCRL2 TICRR FNDC3A GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 | 2.91e-11 | 188 | 144 | 11 | 567b08514d9d84cbb40f9b7a679eec304f023428 |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | FCRL2 GLCCI1 IGHA1 SLC17A9 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 1.03e-10 | 157 | 144 | 10 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | FCRL2 GLCCI1 IGHA1 SLC17A9 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 1.03e-10 | 157 | 144 | 10 | 2cb3deb5313ce734710c601935ca318e4179077e |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | ARHGAP42 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.10e-10 | 158 | 144 | 10 | 17a13c5719eb363f2eb8f1d4e171429c6a1ce1e9 |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | ARHGAP42 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.10e-10 | 158 | 144 | 10 | 1397078f909338fa5fa3b01748db891e5e3fc9e7 |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | ARHGAP42 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.10e-10 | 158 | 144 | 10 | e5451cfe67e882eb0c1eca287740f8ab75370abc |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FCRL2 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.17e-10 | 159 | 144 | 10 | 6ecc3cb2daa5887b59836842be414a00cdcdaeec |
| ToppCell | BAL-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | FCRL2 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.17e-10 | 159 | 144 | 10 | 1827493fb464bbddb2ee23f99472cfbcaf57405b |
| ToppCell | Mild_COVID-19-B_cell-Plasmablast|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | ARHGAP42 TICRR KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 FAM149A | 1.40e-10 | 162 | 144 | 10 | b67f6fb3d7f6093c8ef02398ff8fea4d0fb41a3b |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|World / disease group, cell group and cell class (v2) | NEXMIF RUBCNL MUC19 IGHA1 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 3.35e-10 | 177 | 144 | 10 | 057871e211c6508b2a679d391f3cf0ac7ccfc628 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FCRL2 FNDC3A GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 | 4.17e-10 | 181 | 144 | 10 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FCRL2 FNDC3A GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 | 4.17e-10 | 181 | 144 | 10 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee |
| ToppCell | Control-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | TRIO FNDC3A IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 PTCH2 | 5.44e-10 | 186 | 144 | 10 | a08a50bff4e629588faa22440d57334b1df0e8df |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FCRL2 RUBCNL IGHA1 SLC17A9 IGHA2 IGHE IGHG1 IGHG2 IGHG3 IGHG4 | 5.73e-10 | 187 | 144 | 10 | 8089ae6ee59533a090fe0b19bdd057fba8fa11de |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | ARHGAP42 GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 SLC39A7 | 7.40e-10 | 192 | 144 | 10 | 3d0240491296757b3125f6e861bbaca06bbc5068 |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | ARHGAP42 GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 SLC39A7 | 7.40e-10 | 192 | 144 | 10 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.79e-10 | 193 | 144 | 10 | de0213f2105b814f38ffbfd004ea7603230eed68 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | GLCCI1 PTK7 KANK1 IGHA1 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 SPRED1 | 8.19e-10 | 194 | 144 | 10 | 69828d24b3e182f26aa15eb0ae5aa21c640c2922 |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | ARHGAP42 GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 SLC39A7 | 1.05e-09 | 199 | 144 | 10 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FCRL2 UNC13D GLCCI1 IGHA1 SLC17A9 IGHA2 IGHG1 IGHG2 IGHG3 IGHG4 | 1.05e-09 | 199 | 144 | 10 | 2f60682f1b82918a65e8851e99c9e3398845b62f |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasmablasts|bone_marrow / Manually curated celltypes from each tissue | 3.40e-09 | 164 | 144 | 9 | 67260e9f569f0acaeb0e65f69cde230f91cd3d26 | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 6.01e-09 | 175 | 144 | 9 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.01e-09 | 175 | 144 | 9 | c3d3f11602379aaba65842a98835299e54fccd84 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-09 | 177 | 144 | 9 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-09 | 177 | 144 | 9 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.97e-09 | 178 | 144 | 9 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | normal_Lung-B_lymphocytes|normal_Lung / Location, Cell class and cell subclass | 7.32e-09 | 179 | 144 | 9 | 5b89193486100b6754c1c5eca3105ea955805eae | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.32e-09 | 179 | 144 | 9 | ba7744b903abfc28b39a00472661f152e9ae39fd | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.68e-09 | 180 | 144 | 9 | 6a777a308fa3160d31eda468db930e71862020b2 | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 8.06e-09 | 181 | 144 | 9 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-09 | 181 | 144 | 9 | 5a4fe0eca7cbc9cbc8a2fdbe795a7c5f4052a659 | |
| ToppCell | COPD-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | 8.46e-09 | 182 | 144 | 9 | 19db653fe04c5e2957eea1f4893b1c1fca4ddcbd | |
| ToppCell | (2)_B_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.46e-09 | 182 | 144 | 9 | 8fe9b3a82159a388ffb642ac4f6aff05b8b5f944 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 8.87e-09 | 183 | 144 | 9 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 8.87e-09 | 183 | 144 | 9 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.30e-09 | 184 | 144 | 9 | d18e94839a62fca536ae1630c154e5d0aafc44c5 | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 9.30e-09 | 184 | 144 | 9 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 9.30e-09 | 184 | 144 | 9 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.75e-09 | 185 | 144 | 9 | 3b77bc49cd3740acc025e162a36282ac09e12198 | |
| ToppCell | metastatic_Brain-B_lymphocytes|metastatic_Brain / Location, Cell class and cell subclass | 9.75e-09 | 185 | 144 | 9 | 153b82dc5ace03f84dc82d724d56bdc93aa020df | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.02e-08 | 186 | 144 | 9 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | tumor_Lung-B_lymphocytes|tumor_Lung / Location, Cell class and cell subclass | 1.02e-08 | 186 | 144 | 9 | a54b368d7921185c583e35b532a6898c5486c2fc | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-08 | 186 | 144 | 9 | b9fb7210f615faff0633a1c82dd3be38cb72a00b | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 1.07e-08 | 187 | 144 | 9 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-08 | 187 | 144 | 9 | d2296f2722a24b289fed7e6cfdc2105608437c3e | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.07e-08 | 187 | 144 | 9 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 1.07e-08 | 187 | 144 | 9 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-08 | 187 | 144 | 9 | 06a0f0a27569af89f86ed8cddb608454a3d40cc5 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.12e-08 | 188 | 144 | 9 | 8da631b2c75441b7309f03e7d4c14f15f2367be6 | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 1.12e-08 | 188 | 144 | 9 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-08 | 188 | 144 | 9 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.12e-08 | 188 | 144 | 9 | 064a66cbca5648371d6360cfcb3965845a81c65f | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-08 | 188 | 144 | 9 | 33360f1c30315d9772731c9067834dc059172b79 | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 1.12e-08 | 188 | 144 | 9 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-08 | 188 | 144 | 9 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | Severe_COVID-19-B_cell|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.17e-08 | 189 | 144 | 9 | 59ce8f15f413557d2059ee6b53ba5957b864cb8e | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-08 | 189 | 144 | 9 | b0fcbe13a91a4b8dfa507b7a484f45477ef31609 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-08 | 189 | 144 | 9 | d5d25f4151ea96e2d4b3a0e0910e7ff995eaf752 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-08 | 189 | 144 | 9 | a1bda6ed5c52a5d33d229018cb5982cae6305533 | |
| ToppCell | Severe_COVID-19-B_cell-Plasmablast|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.17e-08 | 189 | 144 | 9 | d7bfefc8c35374c5288807349a76dbb10e84c52b | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-08 | 189 | 144 | 9 | 0f0607642eecc66222d23afe6d77b6872343cb8e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-08 | 189 | 144 | 9 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 1.23e-08 | 190 | 144 | 9 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | BAL-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-08 | 190 | 144 | 9 | e82fefea5ac03470d10463832d3efd2380895860 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class | 1.23e-08 | 190 | 144 | 9 | b6510c419a15ed049c0a0a6a6697b643668741c3 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-08 | 190 | 144 | 9 | 9560722facaf3516936fcbc2a900a405fd85e5d0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-08 | 190 | 144 | 9 | 7de42d8572599693618fb920798a2e52a0b5265c | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-08 | 190 | 144 | 9 | 7fbaf46bf24d46543047582f0d262f3523e28eb4 | |
| ToppCell | BAL-Severe-Lymphocyte-B|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.23e-08 | 190 | 144 | 9 | d55b9f9b82bd2b2e1ea2446813fce04f04a1dcdf | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-08 | 190 | 144 | 9 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.29e-08 | 191 | 144 | 9 | 03f6da73e7b706252d2096507222229c4101a27b | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-08 | 191 | 144 | 9 | 578b58782e816ecaeabfbc616ceb1dcd53ee428b | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.29e-08 | 191 | 144 | 9 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | cellseq2-Immune-Lymphocytic_B-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-08 | 191 | 144 | 9 | 17746a32f723c078aba1f7e320b0e3f1ab8bf5c6 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_B-B_memory|COVID-19_Convalescent / Disease group, lineage and cell class | 1.29e-08 | 191 | 144 | 9 | 4a853cd2434b0f5b18e1f853c37515845046c88b | |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|Lymphoid / Condition, Lineage and Cell class | 1.29e-08 | 191 | 144 | 9 | bcdadf83cb9653f9cc2a281e7c1095fe8f79173c | |
| ToppCell | cellseq2-Immune-Lymphocytic_B|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-08 | 191 | 144 | 9 | c2c450df810f83163987cd0f7ed9b50025cd3de1 | |
| ToppCell | Severe-Lymphoid-Plasma|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-08 | 192 | 144 | 9 | 8d26584c7897a2c77df9efe787e7c04d1e883df9 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.35e-08 | 192 | 144 | 9 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | Severe-Lymphoid-Plasma-|Severe / Condition, Lineage, Cell class and cell subclass | 1.35e-08 | 192 | 144 | 9 | 3a900d872da80b47104245440eb09b8c80b0b2b0 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 1.35e-08 | 192 | 144 | 9 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.35e-08 | 192 | 144 | 9 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | VE-naiveBc-|VE / Condition, Cell_class and T cell subcluster | 1.35e-08 | 192 | 144 | 9 | bca2aec4811627225fccd92abe2f3b1ba729c9ce | |
| ToppCell | VE-naiveBc|VE / Condition, Cell_class and T cell subcluster | 1.35e-08 | 192 | 144 | 9 | 87cdda9a170f6f2fa56d0ed1d3fd2f93bfe09aa1 | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 1.41e-08 | 193 | 144 | 9 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.41e-08 | 193 | 144 | 9 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-08 | 193 | 144 | 9 | 89831e1007944e47719e58f23bfef5f1944cae23 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.41e-08 | 193 | 144 | 9 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-08 | 193 | 144 | 9 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-08 | 193 | 144 | 9 | 0373984547cefc0cbd77f8e795d508f6fcebc6c8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-08 | 194 | 144 | 9 | fb850d99bc1ce52c9ea8080199e6322902fd63a0 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-08 | 194 | 144 | 9 | c531c1759a3dfbc85d00ed5eaba35cd14b1b2ac1 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-08 | 194 | 144 | 9 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-08 | 194 | 144 | 9 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-08 | 195 | 144 | 9 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-08 | 196 | 144 | 9 | c38e7f533c619afe008de0e99042f7180c2da918 | |
| ToppCell | tumor_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.61e-08 | 196 | 144 | 9 | 1f63dba9d226e4a42d9bee7258580a1e547c0e92 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.31e-06 | 49 | 78 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.48e-06 | 50 | 78 | 6 | GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA | |
| Disease | di-N-acetylchitobiase measurement | 3.90e-07 | 4 | 137 | 3 | EFO_0801524 | |
| Disease | beta-sarcoglycan measurement | 1.94e-06 | 6 | 137 | 3 | EFO_0801422 | |
| Disease | TPE interval measurement | 4.37e-06 | 52 | 137 | 5 | EFO_0004644 | |
| Disease | Metastatic melanoma | 5.28e-06 | 54 | 137 | 5 | C0278883 | |
| Disease | Squamous cell carcinoma of lung | 1.45e-05 | 32 | 137 | 4 | C0149782 | |
| Disease | neural cell adhesion molecule 1 measurement | 2.14e-05 | 2 | 137 | 2 | EFO_0801826 | |
| Disease | insulin growth factor-like family member 4 measurement | 2.14e-05 | 2 | 137 | 2 | EFO_0801701 | |
| Disease | immunoglobulin G measurement | 2.14e-05 | 2 | 137 | 2 | EFO_0020465 | |
| Disease | ameloblastin measurement | 6.40e-05 | 3 | 137 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 6.40e-05 | 3 | 137 | 2 | EFO_0801866 | |
| Disease | secretoglobin family 1C member 1 measurement | 6.40e-05 | 3 | 137 | 2 | EFO_0802041 | |
| Disease | HLA class II histocompatibility antigen, DM alpha chain measurement | 6.40e-05 | 3 | 137 | 2 | EFO_0801684 | |
| Disease | Brugada ECG Pattern | 1.28e-04 | 4 | 137 | 2 | C1721096 | |
| Disease | AQP4-IgG-positive neuromyelitis optica | 1.28e-04 | 4 | 137 | 2 | EFO_0009584 | |
| Disease | trem-like transcript 4 protein measurement | 1.28e-04 | 4 | 137 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 1.28e-04 | 4 | 137 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 1.28e-04 | 4 | 137 | 2 | EFO_0802027 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 2.12e-04 | 5 | 137 | 2 | EFO_0801901 | |
| Disease | Myositis, Proliferative | 2.12e-04 | 5 | 137 | 2 | C0544796 | |
| Disease | Infectious Myositis | 2.12e-04 | 5 | 137 | 2 | C0158353 | |
| Disease | protein shisa-3 homolog measurement | 2.12e-04 | 5 | 137 | 2 | EFO_0801964 | |
| Disease | Myositis | 2.12e-04 | 5 | 137 | 2 | C0027121 | |
| Disease | Myositis, Focal | 2.12e-04 | 5 | 137 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 2.12e-04 | 5 | 137 | 2 | C0751356 | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 3.17e-04 | 6 | 137 | 2 | EFO_0801456 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 3.17e-04 | 6 | 137 | 2 | EFO_0801810 | |
| Disease | complement C1q subcomponent measurement | 3.17e-04 | 6 | 137 | 2 | EFO_0008089 | |
| Disease | 1,5 anhydroglucitol measurement | 3.27e-04 | 29 | 137 | 3 | EFO_0008009 | |
| Disease | paracoccidioidomycosis (is_marker_for) | 4.43e-04 | 7 | 137 | 2 | DOID:12662 (is_marker_for) | |
| Disease | electrocardiography, PR interval | 4.43e-04 | 7 | 137 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | inducible T-cell costimulator measurement | 4.43e-04 | 7 | 137 | 2 | EFO_0021967 | |
| Disease | sialic acid-binding Ig-like lectin 10 measurement | 4.43e-04 | 7 | 137 | 2 | EFO_0802064 | |
| Disease | urate measurement, bone density | ERBB4 DSCAM CFB DDX10 ARHGAP22 PRKDC DMBT1 USH2A TNXB PRRC2B | 6.50e-04 | 619 | 137 | 10 | EFO_0003923, EFO_0004531 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.35e-04 | 152 | 137 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | supraventricular ectopy | 7.54e-04 | 9 | 137 | 2 | EFO_0009277 | |
| Disease | Parkinson disease, disease progression measurement | 7.92e-04 | 39 | 137 | 3 | EFO_0008336, MONDO_0005180 | |
| Disease | complement C1q subcomponent subunit C measurement | 9.40e-04 | 10 | 137 | 2 | EFO_0801492 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 9.40e-04 | 10 | 137 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 9.40e-04 | 10 | 137 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | polymeric immunoglobulin receptor measurement | 9.40e-04 | 10 | 137 | 2 | EFO_0008267 | |
| Disease | axin-2 measurement | 9.40e-04 | 10 | 137 | 2 | EFO_0801400 | |
| Disease | multimerin-2 measurement | 9.40e-04 | 10 | 137 | 2 | EFO_0801809 | |
| Disease | Neurodevelopmental Disorders | 9.43e-04 | 93 | 137 | 4 | C1535926 | |
| Disease | immunoglobulin isotype switching measurement | 1.13e-03 | 44 | 137 | 3 | EFO_0010128 | |
| Disease | neuroticism measurement, cognitive function measurement | CACNA1E ERBB4 CTTNBP2 DSCAM PCDHA13 PCDHA8 PCDHA6 KLHL29 PROC | 1.35e-03 | 566 | 137 | 9 | EFO_0007660, EFO_0008354 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.37e-03 | 12 | 137 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Sudden infant death syndrome | 1.37e-03 | 12 | 137 | 2 | C0038644 | |
| Disease | wellbeing measurement | CACNA1E ERBB4 CTTNBP2 DSCAM MUC19 KLHL29 TEX22 PTPRQ TNXB SDK1 | 1.50e-03 | 692 | 137 | 10 | EFO_0007869 |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.61e-03 | 13 | 137 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Brugada Syndrome 1 | 1.61e-03 | 13 | 137 | 2 | C4551804 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 1.61e-03 | 13 | 137 | 2 | EFO_0010617 | |
| Disease | sitting height ratio | 1.73e-03 | 51 | 137 | 3 | EFO_0007118 | |
| Disease | T wave morphology measurement | 1.88e-03 | 14 | 137 | 2 | EFO_0008398 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.16e-03 | 15 | 137 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.16e-03 | 15 | 137 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | P wave duration | 2.16e-03 | 15 | 137 | 2 | EFO_0005094 | |
| Disease | Romano-Ward Syndrome | 2.46e-03 | 16 | 137 | 2 | C0035828 | |
| Disease | sex interaction measurement, ulcerative colitis | 2.78e-03 | 17 | 137 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.78e-03 | 17 | 137 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | retinal vasculature measurement | 2.94e-03 | 517 | 137 | 8 | EFO_0010554 | |
| Disease | risk-taking behaviour | CACNA1E ZNF536 KIF26A FBXO11 KLHL29 NEO1 IGF1R TNXB SDK1 PROC | 3.07e-03 | 764 | 137 | 10 | EFO_0008579 |
| Disease | response to methotrexate, juvenile idiopathic arthritis | 3.47e-03 | 19 | 137 | 2 | EFO_0002609, GO_0031427 | |
| Disease | Brugada syndrome | 3.47e-03 | 19 | 137 | 2 | MONDO_0015263 | |
| Disease | depressive symptom measurement | 3.84e-03 | 426 | 137 | 7 | EFO_0007006 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.24e-03 | 21 | 137 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ERBB4 CTTNBP2 KIF26A FBXO11 KLHL29 IGF1R PRKDC USH2A SDK1 PRRC2B | 4.28e-03 | 801 | 137 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THGAETLTLWQSTGP | 161 | Q6UXC1 | |
| LSLGSTINWGGTEKP | 51 | P55087 | |
| WPSNLTLVSTNGSSG | 171 | Q15303 | |
| VISSNWSGLQTESIP | 26 | P41595 | |
| AGSLGVWVQDTPFST | 306 | Q9N2K0 | |
| AGSLGVWVQDTPFST | 306 | Q9N2J8 | |
| EQPLSWFSGLLGSSS | 236 | Q8IYX3 | |
| ALLTLFTVSTGEGWP | 1361 | Q15878 | |
| NGDTSISITGPWISL | 256 | Q6ZNE5 | |
| IGAIWSSTSPDFGVN | 176 | Q86V21 | |
| LQTGTPWESVTFTAL | 126 | Q9Y276 | |
| EFWPGLTSLTLGSGQ | 151 | Q12774 | |
| SLSVTSLGGLPQWEV | 6 | P54840 | |
| LSAVAASTEWGAVSP | 196 | A6NE02 | |
| EFWPGLTSLTLGSGQ | 151 | A5YM69 | |
| TTRELLLPNWQGSGS | 6 | Q09666 | |
| SSLDTITGPYLTGQW | 171 | Q86VQ1 | |
| APGLTGSEWTRTVLS | 411 | Q9C0C7 | |
| GLAQPEAQITTWSTG | 511 | Q96HY7 | |
| ITWDPTGSRLLTGSS | 116 | Q9Y485 | |
| TSSGGETLWNLPAIK | 306 | Q96F81 | |
| TLSQWSLGNGTPVTS | 811 | Q7Z2K6 | |
| EGFIQSISLSVPWGS | 71 | Q96BY7 | |
| AVWGTFLPTTLTGLG | 1331 | Q9UKP4 | |
| SGVSGVLTATLLPNW | 16 | P56880 | |
| TNLDVAGPTWTSTAL | 161 | Q2M1V0 | |
| LLTTIPQIGSTEWSE | 251 | Q13126 | |
| SWSKEVSGLLGSDQP | 236 | Q9H714 | |
| SWLPVTIDSAGSSNG | 1106 | A6NNM3 | |
| SWLPVTIDSAGSSNG | 1106 | A6NJZ7 | |
| LSGNSPKTGTSEWAV | 226 | Q9NZM3 | |
| GSPSLWATASLSVEV | 431 | Q9UN73 | |
| LGLLSGGVTTTPWSL | 16 | P00751 | |
| LVWGTKSSPGLSDTI | 11 | Q9H8M7 | |
| GSPSLWATASLSVEV | 431 | Q9Y5H6 | |
| PSSWETLVQGLSGLT | 151 | Q8NDB6 | |
| SGGEASLWDIPINSS | 656 | O75420 | |
| ETSVTPSNLWGGQGL | 81 | Q9H8Y8 | |
| GLWSTASSQRVSPGL | 261 | Q9UGP4 | |
| VSIWITSRPSASGQI | 261 | Q7RTR2 | |
| TWTGQSILTGSQYVP | 741 | A5PLN7 | |
| INEGSPLWTSIGAST | 71 | P16150 | |
| VVLWDLPGTGSATTT | 86 | A1A4Y4 | |
| QATSLSGNGSWTDPV | 906 | P08069 | |
| TRLEPTWSIINGSTA | 1026 | P51805 | |
| LLIWVTTIGSPSLGS | 41 | Q8NH70 | |
| ITGSGTTRPLVTESW | 3101 | Q7Z5P9 | |
| GTTWPSAVVTGISGL | 5201 | Q7Z5P9 | |
| AGVTGTTVPLAGVTW | 5956 | Q7Z5P9 | |
| ISLPWGAQGTASTSL | 36 | P09131 | |
| EIPSINIIWTSSSLG | 191 | A0A1B0GTH6 | |
| LTLWEQGSPGTSYSL | 296 | Q496M5 | |
| PRTTSGQQGIWTSTE | 76 | Q14678 | |
| TTLGVTTPAVSWGDA | 1311 | Q9ULI4 | |
| LIPTGTQSLWVGNSD | 36 | Q8WVL7 | |
| PLWVTLGSSSPTESL | 716 | Q32M88 | |
| TGNITGKSFSILWDP | 356 | Q9UMZ3 | |
| GSPSLWATASVSVGV | 431 | Q9Y5I0 | |
| VDSSAIIWGVGSNSL | 356 | O43283 | |
| SLLLFVATWGISGTP | 6 | P04070 | |
| TSWEKGSLVSPGGLQ | 1001 | Q460N5 | |
| LLPTSAQGLGAWVSA | 21 | P24001 | |
| SIRSITLGNVPWSVG | 1051 | Q8WZ74 | |
| AGVWITSNSDPTIRG | 526 | Q86XK2 | |
| TLAGVWVTTGSTPVL | 616 | Q86XK2 | |
| ASSITLTWIPGDNGG | 1396 | Q8TD84 | |
| SLGPWGITNGSATAI | 796 | Q5T0N1 | |
| WGEGTPKTLSTDSIQ | 971 | Q9Y2H6 | |
| ISSVNGTSVTLEWAP | 336 | P29322 | |
| GSSLGTEWQTPVISE | 26 | Q6P2H3 | |
| PLSVTWSESGQGVTA | 36 | P01876 | |
| PSKGTVNLTWSRASG | 246 | P01854 | |
| VWLPSSGQVSAQRTG | 26 | Q12894 | |
| TEGTTSPWTAIDLQG | 191 | Q6UWN5 | |
| GLESGSLIPSASSWN | 456 | P09913 | |
| SWLTLSGPEQSSVRG | 1081 | Q92538 | |
| PLSVTWSESGQNVTA | 36 | P01877 | |
| PVTVSWNSGALTSGV | 36 | P01857 | |
| PVTVSWNSGALTSGV | 36 | P01859 | |
| PVTVSWNSGALTSGV | 36 | P01860 | |
| PVTVSWNSGALTSGV | 36 | P01861 | |
| WTSTDGLGVLIISPT | 136 | Q13206 | |
| VLGSGWSSSPELQIS | 151 | Q96LA5 | |
| TTPVEGSLSWTLGKR | 281 | P48728 | |
| INSATGWVSVSGPLD | 701 | Q9NYQ7 | |
| TWLTTNLPALTVGSE | 1621 | Q9UGM3 | |
| SEITSTTLNVSWGEP | 1811 | Q7Z5N4 | |
| AIQLTPGESSKTWGR | 561 | P80192 | |
| SSPGGLSLGNVTAWQ | 351 | Q14814 | |
| GVPRALGETWNSSLS | 2441 | Q6ZRI0 | |
| TSSSITLSWLPGDNG | 1391 | O60469 | |
| TLTWTTLSNQSGPIE | 1166 | O75445 | |
| STEWGLPSIVKSLIG | 56 | Q9Y3B1 | |
| SWTGTVISDSVPGSQ | 16 | Q9GZN6 | |
| TDGKTLPSWGQALLS | 236 | P08582 | |
| SNGQKSLGLWTTSPE | 671 | A6NI28 | |
| SWLPVTIDSAGSSNG | 1106 | Q9UFD9 | |
| LTSGIAKGLNTWSLP | 101 | Q5QGS0 | |
| TVWVSSDPLGLAASQ | 861 | Q9Y6C5 | |
| ALTINGTGPATDWLS | 711 | Q92859 | |
| QITTSAGWDGLLSPI | 1706 | Q14524 | |
| GTSVTGGQTVLNPWI | 156 | P49903 | |
| SASAWGSITAVTPLL | 96 | Q9BYT1 | |
| VIPGLQWFIGKSTSS | 301 | Q8TF17 | |
| IDGSSPVSILVWTTQ | 286 | Q9NSE4 | |
| WVPALVSGSVNGTIT | 211 | Q5H9E4 | |
| VLSGGNVDLTSSITW | 311 | Q9GZT4 | |
| QSWTVGKLELLSSGP | 941 | Q9UHV7 | |
| GSSLEVPIISSGGNW | 446 | Q7Z5H3 | |
| VLQSGQSWSPTRSGV | 101 | Q9UHD4 | |
| QSWSPTRSGVLSYGL | 106 | Q9UHD4 | |
| LSGSLQSLWRAVTGP | 151 | Q7RTV5 | |
| INWTTGTASGGDPLT | 186 | O75443 | |
| DGSSSLPNVSLAWVI | 61 | Q86UV6 | |
| TTEGLTGLWKGTTPN | 166 | P25874 | |
| LGLIAAWGQPSIQSS | 26 | C9J3V5 | |
| NLTWSSSGGDEKVLP | 71 | Q70EK9 | |
| VAQWSLPTSSTLGTD | 346 | Q7Z2Z1 | |
| LSPEQGTGIISGKSW | 166 | Q96BR9 | |
| NLPRTNGVGSLITTW | 276 | P50443 | |
| SGQGPILSVGLWVLS | 211 | Q92504 | |
| QITTSAGWDGLLSPI | 1656 | Q9Y5Y9 | |
| GLSTPNTIDQWDTTG | 86 | Q15796 | |
| WLPLGGSGLSSVTVF | 31 | Q7Z699 | |
| GPANQTLVLGSSVWL | 456 | Q96MS0 | |
| VLGNTSGLWSTTPFS | 1791 | Q92545 | |
| NPAWSVSTILTGLLS | 106 | Q8N2K1 | |
| TSDSLSLSWTVPEGQ | 2206 | P22105 | |
| LTVTDATPDSVGLSW | 3361 | P22105 | |
| VSVTTGPWGAVATSA | 26 | Q9BX74 | |
| VTVPGSSLGTEIWES | 1616 | Q5JSZ5 | |
| EIARWGQTLPTTSST | 2531 | Q9H254 | |
| ISTLSGNPLDNGWTL | 386 | Q68DE3 | |
| SSSGIWANTSPEAEL | 466 | Q12899 | |
| FWSGSETSGLLTKPV | 576 | Q9BQI6 | |
| GEASTLTIWDLASPT | 551 | Q04726 | |
| ATILSWTGLATPTGV | 2191 | P78527 | |
| SLPGSSVTVQDSIAW | 986 | O15090 | |
| VALTLTPGWTQLDSS | 226 | Q969J2 | |
| DGSSSLPNVSLAWVI | 61 | Q86UV7 | |
| LSTLGQIDGWSSTQL | 1551 | A6NGW2 | |
| VVGTLTPSSVFLSWG | 121 | Q7Z7G0 | |
| QTTSSISLSWEVPDG | 41 | Q9HD43 | |
| GSSLPEWVTDNAGTL | 541 | Q13308 | |
| TSWDGSLSPQAATVL | 321 | Q70J99 | |
| FQWEGVSISSSPGLA | 841 | Q9H2Y7 | |
| GNPVSLTSDTWSVGV | 2966 | O75962 | |
| PGSLSVVTTVWGVTN | 161 | Q9ULJ6 | |
| STWISSLSQIRGAVP | 1701 | Q9BYP7 | |
| SQGLATSIRWGQTPI | 106 | Q96CT2 | |
| VTEVTATSGLVSWGP | 411 | Q6PJG9 | |
| IGSGTWEAISSESPV | 541 | Q5VTT5 |